208 related articles for article (PubMed ID: 21125820)
1. Arginine-glycine-aspartic acid-conjugated dendrimer-modified quantum dots for targeting and imaging melanoma.
Li Z; Huang P; Lin J; He R; Liu B; Zhang X; Yang S; Xi P; Zhang X; Ren Q; Cui D
J Nanosci Nanotechnol; 2010 Aug; 10(8):4859-67. PubMed ID: 21125820
[TBL] [Abstract][Full Text] [Related]
2. RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy.
Li Z; Huang P; Zhang X; Lin J; Yang S; Liu B; Gao F; Xi P; Ren Q; Cui D
Mol Pharm; 2010 Feb; 7(1):94-104. PubMed ID: 19891496
[TBL] [Abstract][Full Text] [Related]
3. [In situ visual imaging of oral squamous cell carcinoma in mice by using near-infrared quantum dots conjugated with arginine-glycine-aspartic acid peptide fluorescent probes].
Yunlong B; Hao H; Kai Y; Hong T
Hua Xi Kou Qiang Yi Xue Za Zhi; 2014 Oct; 32(5):498-503. PubMed ID: 25490831
[TBL] [Abstract][Full Text] [Related]
4. Toxicity assessment of repeated intravenous injections of arginine-glycine-aspartic acid peptide conjugated CdSeTe/ZnS quantum dots in mice.
Wang YW; Yang K; Tang H; Chen D; Bai YL
Int J Nanomedicine; 2014; 9():4809-17. PubMed ID: 25378922
[TBL] [Abstract][Full Text] [Related]
5. Chemical nature and structure of organic coating of quantum dots is crucial for their application in imaging diagnostics.
Bakalova R; Zhelev Z; Kokuryo D; Spasov L; Aoki I; Saga T
Int J Nanomedicine; 2011; 6():1719-32. PubMed ID: 21980235
[TBL] [Abstract][Full Text] [Related]
6. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
7. Effects of arginine-glycine-aspartic acid peptide-conjugated quantum dots-induced photodynamic therapy on pancreatic carcinoma in vivo.
Li MM; Cao J; Yang JC; Shen YJ; Cai XL; Chen YW; Qu CY; Zhang Y; Shen F; Xu LM
Int J Nanomedicine; 2017; 12():2769-2779. PubMed ID: 28435257
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Cancer Dual-Targeting and Dual-Modality Imaging with Functionalized Quantum Dots.
Hu K; Wang H; Tang G; Huang T; Tang X; Liang X; Yao S; Nie D
J Nucl Med; 2015 Aug; 56(8):1278-84. PubMed ID: 26112023
[TBL] [Abstract][Full Text] [Related]
9. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.
Cai W; Shin DW; Chen K; Gheysens O; Cao Q; Wang SX; Gambhir SS; Chen X
Nano Lett; 2006 Apr; 6(4):669-76. PubMed ID: 16608262
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and toxicity assessment of intratumorally injected arginine-glycine-aspartic acid peptide conjugated to CdSe/ZnS quantum dots in mice bearing pancreatic neoplasm.
Li MM; Cao J; Yang JC; Shen YJ; Cai XL; Chen YW; Qu CY; Zhang Y; Shen F; Zhou M; Xu LM
Chem Biol Interact; 2018 Aug; 291():103-110. PubMed ID: 29908985
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of iron oxide nanoparticles with RGD-modified dendrimers for targeted tumor MR imaging.
Yang J; Luo Y; Xu Y; Li J; Zhang Z; Wang H; Shen M; Shi X; Zhang G
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5420-8. PubMed ID: 25695661
[TBL] [Abstract][Full Text] [Related]
12. Quantum dots-bevacizumab complexes for in vivo imaging of tumors.
Gazouli M; Bouziotis P; Lyberopoulou A; Ikonomopoulos J; Papalois A; Anagnou NP; Efstathopoulos EP
In Vivo; 2014; 28(6):1091-5. PubMed ID: 25398804
[TBL] [Abstract][Full Text] [Related]
13. Quantum dot loaded immunomicelles for tumor imaging.
Papagiannaros A; Upponi J; Hartner W; Mongayt D; Levchenko T; Torchilin V
BMC Med Imaging; 2010 Oct; 10():22. PubMed ID: 20955559
[TBL] [Abstract][Full Text] [Related]
14. Aqueous synthesized near-infrared-emitting quantum dots for RGD-based in vivo active tumour targeting.
Lu Y; Zhong Y; Wang J; Su Y; Peng F; Zhou Y; Jiang X; He Y
Nanotechnology; 2013 Apr; 24(13):135101. PubMed ID: 23478489
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes.
Dijkgraaf I; Rijnders AY; Soede A; Dechesne AC; van Esse GW; Brouwer AJ; Corstens FH; Boerman OC; Rijkers DT; Liskamp RM
Org Biomol Chem; 2007 Mar; 5(6):935-44. PubMed ID: 17340009
[TBL] [Abstract][Full Text] [Related]
16. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
[TBL] [Abstract][Full Text] [Related]
17. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
[TBL] [Abstract][Full Text] [Related]
18. RGD-conjugated PLA-PLL nanoparticles targeting to Bacp-37 breast cancer xenografts in vivo.
Liu P; Qi X; Sun Y; Wang H; Li Y; Duan Y
J Nanosci Nanotechnol; 2011 Dec; 11(12):10760-4. PubMed ID: 22408990
[TBL] [Abstract][Full Text] [Related]
19. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
[TBL] [Abstract][Full Text] [Related]
20. Efficient assembly of multi-walled carbon nanotube-CdSe/ZnS quantum dot hybrids with high biocompatibility and fluorescence property.
Zhang Y; Qin W; Tang H; Yan F; Tan L; Xie Q; Ma M; Zhang Y; Yao S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):346-52. PubMed ID: 21680161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
